神经周围侵犯对胰头导管腺癌切除术后复发与生存的影响
这项多中心回顾性研究纳入2009至2014年778例胰头导管腺癌切除患者,评估神经周围侵犯(PNI)对无病生存(DFS)和总生存(OS)的影响。PNI见于87%患者,在R0/N0肿瘤中为70.6%,≤20 mm肿瘤中为78.7%。PNI是R0/N0肿瘤(HR 2.2)和≤20 mm肿瘤(HR 1.8)DFS的唯一独立预测因素,也是全队列OS的独立预测因素(27 vs 50个月,P=0.01)。
要点
- PNI在可切除胰头导管腺癌中极为常见,总体发生率为87%。
- 在R0/N0和≤20 mm早期肿瘤中,PNI仍是DFS的独立预测因素。
- PNI是全队列OS的独立预测因素,中位OS为27 vs 50个月。
核心结论
- PNI是胰腺癌肿瘤复发和患者生存的主要决定因素。
- PNI在早期阶段的作用尤为突出,支持癌细胞侵犯神经在胰腺癌进展中具有驱动作用的假说。
研究设计与样本
- 多中心回顾性研究,纳入2009至2014年间接受PDAC切除术的患者。
- 共纳入778例患者,采用Cox比例风险模型分析PNI与DFS和OS的关联。
主要发现
- PNI见于87%的778例患者,在PDAC≤20 mm中为78.7%,在R0/N0肿瘤中为70.6%。
- 接受新辅助治疗与直接手术的患者PNI率无差异(88% vs 84%,P=0.08)。
- 单因素分析中PNI患者DFS更差(中位DFS:20 vs 15个月,P<0.01),但多因素分析未达显著(P=0.07)。
- PNI是R0/N0肿瘤(HR 2.2)和PDAC≤20 mm(HR 1.8)DFS的唯一独立预测因素。
- PNI是全队列OS的独立预测因素(27 vs 50个月,P=0.01),其他因素包括G3肿瘤、pN1状态、CA19.9>37和疼痛。
临床怎么用
- 对于R0/N0和≤20 mm的早期胰头导管腺癌,应将PNI作为复发风险评估的重要病理指标。
- PNI阳性患者即使处于早期阶段,也应加强术后随访和复发监测。
局限性
- 本研究为回顾性研究设计。
- PNI对DFS的多因素分析未达统计学显著(P=0.07)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe PNI and to evaluate its impact on disease-free (DFS) and overall survival (OS) in patients with resected pancreatic ductal adenocarcinoma (PDAC). SUMMARY OF BACKGROUND DATA: Although PNI is a prognostic factor for survival in many GI cancers, there is limited knowledge regarding its impact on tumor recurrence, especially in ''early stage disease'' (PDAC ≤20 mm, R0/ N0 PDAC). METHODS: This multicenter retrospective study included patients undergoing PDAC resection between 2009 and 2014. The association of PNI with DFS and OS was analyzed using Cox proportional-hazards models. RESULTS: PNI was found in 87% of 778 patients included in the study, with lower rates in PDAC ≤20 mm (78.7%) and in R0/N0 tumors (70.6%). PNI rate did not differ between patients who underwent neoadjuvant therapy and upfront surgery (88% vs 84%, P = 0.08). Although not significant at multivariate analysis ( P = 0.07), patients with PNI had worse DFS at univariate analysis (median DFS: 20 vs 15 months, P < 0.01). PNI was the only independent predictor of DFS in R0/N0 tumors (hazard ratio [HR]: 2.2) and in PDAC ≤ 20 mm (HR: 1.8). PNI was an independent predictor of OS in the entire cohort (27 vs 50 months, P = 0.01), together with G3 tumors, pN1 status, carbohydrate antigen (CA) 19.9 >37 and pain. CONCLUSIONS: PNI represents a major determinant of tumor recurrence and patients' survival in pancreatic cancer. The role of PNI is particularly relevant in early stages, supporting the hypothesis that invasion of nerves by cancer cells has a driving role in pancreatic cancer progression.
引用
- Crippa S, Pergolini I, Javed AA, et al. Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma. Ann Surg. 2020. PMID: 33086324. doi:10.1097/SLA.0000000000004464
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。